Literature DB >> 6664831

Changes of collateral perfusion pressure and segmental coronary resistances during reactive hyperemia in anesthetized dogs.

M Fuchs, G Ertl, A Falcke.   

Abstract

Changes of collateral perfusion pressure (CPP) and segmental coronary resistances during reactive hyperemia were studied in nine chloralose-urethan-morphine anesthetized open-chest dogs. Coronary perfusion pressure was controlled by a cannula in the left main coronary artery and inflow measured by an electromagnetic flowmeter. The first or second diagonal branch of the left anterior descending coronary artery was cannulated and perfused from a carotid artery; inflow was abolished by embolization with latex microspheres (diameter: 25 +/- 5 mu) and peripheral coronary pressure was assumed to represent CPP. Segmental coronary resistances were defined as follows: Proximal coronary resistance (R1) was calculated from the difference between coronary perfusion pressure and CPP divided by coronary inflow. Distal coronary resistance (R2) was calculated from CPP divided by coronary inflow. Reactive hyperemia was produced by interruption of coronary inflow for 15 s and analysed at 30 s and 60 s of reperfusion when cardiac function had recovered. At baseline, R1 was 0.52 +/- 0.04 mm Hg X min X 100 g/ml (RU) and R2 0.63 +/- 0.07 RU. At 30 s, R1 was reduced by 19 +/- 3% (P less than 0.01) this was less (P less than 0.05) than R2 which was reduced by 32 +/- 3% (P less than 0.01). At 60 s R1 and R2 were reduced by 11 +/- 2% and 13 +/- 2%, respectively; this was not significantly different. Accordingly, CPP (baseline: 59 +/- 4 mm Hg) at 30 s was reduced by 7 +/- 2% (P less than 0.03), at 60 s the reduction was not significant. The data suggest that reactive hyperemia, as a model of metabolic coronary dilatation, may reduce CPP equivalent to a coronary steal phenomenon.

Entities:  

Mesh:

Year:  1983        PMID: 6664831     DOI: 10.1007/bf00652754

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  16 in total

1.  Myocardial reactive hyperemia.

Authors:  R A Olsson
Journal:  Circ Res       Date:  1975-09       Impact factor: 17.367

2.  Segmental alpha-receptor-mediated vasoconstriction in the canine coronary circulation.

Authors:  K O Kelley; E O Feigl
Journal:  Circ Res       Date:  1978-12       Impact factor: 17.367

3.  [Measurement of collateral blood flow in dog hearts by means of selective embolization of a coronary artery].

Authors:  F W Schulz; W K Raff; U Meyer; W Lochner
Journal:  Pflugers Arch       Date:  1973-07-06       Impact factor: 3.657

4.  Effect of nitroglycerin and dipyridamole on regional coronary resistance.

Authors:  W M Fam; M McGregor
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

5.  Release of adenosine in reactive hyperemia of the dog heart.

Authors:  R Rubio; R M Berne; M Katori
Journal:  Am J Physiol       Date:  1969-01

6.  Regulation of large coronary arteries by increases in myocardial metabolic demands in conscious dogs.

Authors:  P Macho; T H Hintze; S F Vatner
Journal:  Circ Res       Date:  1981-09       Impact factor: 17.367

7.  Pharmacological alterations of coronary collateral circulation; implication to the steal-phenomenon.

Authors:  J Wichmann; R Löser; H P Diemer; W Lochner
Journal:  Pflugers Arch       Date:  1978-03-20       Impact factor: 3.657

8.  Coronary collateral flow: effect of drugs and perfusion pressure.

Authors:  H P Diemer; J Wichmann; W Lochner
Journal:  Basic Res Cardiol       Date:  1977 Jul-Aug       Impact factor: 17.165

9.  A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental results.

Authors:  F Simm; G Ertl
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

10.  The pressure-resistance relationships of regional resistances within the coronary circulation and the steal phenomenon.

Authors:  J Wichmann; W Lochner; R Löser; H P Diemer
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.